Results Recursion Pharmaceuticals Inc.
-
Recursion Pharmaceuticals Inc.
Statement of Changes in Beneficial Ownership (Form 4)
-5d
-
Recursion Pharmaceuticals Inc.
MIT and Recursion Launch an Open‑Source Protein Co‑Folding Model Accelerated by NVIDIA
9/15
-
Recursion Pharmaceuticals Inc.
Rising Leaders 2025: Daniel Cohen’s Transition From Grad To AI Pioneer In Drug Discovery
9/15
-
Recursion Pharmaceuticals Inc.
Statement of Changes in Beneficial Ownership (Form 4)
9/12
-
Recursion Pharmaceuticals Inc.
Notice of Proposed Sale of Securities (Form 144)
9/10
-
Recursion Pharmaceuticals Inc.
Amendment to Current Report (Form 8-K/A)
8/29
-
Recursion Pharmaceuticals Inc.
Supplemental Prospectus (Form 424B7)
8/29
-
Recursion Pharmaceuticals Inc.
Statement of Changes in Beneficial Ownership (Form 4)
8/28
-
Recursion Pharmaceuticals Inc.
Notice of Proposed Sale of Securities (Form 144)
8/26
-
Recursion Pharmaceuticals Inc.
8/25